JP2023123627A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023123627A5 JP2023123627A5 JP2023101662A JP2023101662A JP2023123627A5 JP 2023123627 A5 JP2023123627 A5 JP 2023123627A5 JP 2023101662 A JP2023101662 A JP 2023101662A JP 2023101662 A JP2023101662 A JP 2023101662A JP 2023123627 A5 JP2023123627 A5 JP 2023123627A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- pharmaceutical composition
- subject
- masp
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025072148A JP2025108730A (ja) | 2017-08-15 | 2025-04-24 | 造血幹細胞移植に関連する移植片対宿主病および／またはびまん性肺胞出血および／または静脈閉塞症を治療および／または予防するための方法 |
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762545864P | 2017-08-15 | 2017-08-15 | |
| US62/545,864 | 2017-08-15 | ||
| US201762574690P | 2017-10-19 | 2017-10-19 | |
| US62/574,690 | 2017-10-19 | ||
| US201862630756P | 2018-02-14 | 2018-02-14 | |
| US62/630,756 | 2018-02-14 | ||
| US201862637281P | 2018-03-01 | 2018-03-01 | |
| US62/637,281 | 2018-03-01 | ||
| JP2020508563A JP2020531452A (ja) | 2017-08-15 | 2018-08-14 | 造血幹細胞移植に関連する移植片対宿主病および／またはびまん性肺胞出血および／または静脈閉塞症を治療および／または予防するための方法 |
| PCT/US2018/046690 WO2019036460A1 (en) | 2017-08-15 | 2018-08-14 | METHODS OF TREATING AND / OR PREVENTING HOST GRAFT DISORDER AND / OR DIFFUSE ALVEOLAR HEMORRHAGE AND / OR VENO-OCCLUSIVE DISEASE ASSOCIATED WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020508563A Division JP2020531452A (ja) | 2017-08-15 | 2018-08-14 | 造血幹細胞移植に関連する移植片対宿主病および／またはびまん性肺胞出血および／または静脈閉塞症を治療および／または予防するための方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025072148A Division JP2025108730A (ja) | 2017-08-15 | 2025-04-24 | 造血幹細胞移植に関連する移植片対宿主病および／またはびまん性肺胞出血および／または静脈閉塞症を治療および／または予防するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023123627A JP2023123627A (ja) | 2023-09-05 |
| JP2023123627A5 true JP2023123627A5 (https=) | 2024-02-09 |
Family
ID=65362042
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020508563A Pending JP2020531452A (ja) | 2017-08-15 | 2018-08-14 | 造血幹細胞移植に関連する移植片対宿主病および／またはびまん性肺胞出血および／または静脈閉塞症を治療および／または予防するための方法 |
| JP2023101662A Pending JP2023123627A (ja) | 2017-08-15 | 2023-06-21 | 造血幹細胞移植に関連する移植片対宿主病および／またはびまん性肺胞出血および／または静脈閉塞症を治療および／または予防するための方法 |
| JP2025072148A Pending JP2025108730A (ja) | 2017-08-15 | 2025-04-24 | 造血幹細胞移植に関連する移植片対宿主病および／またはびまん性肺胞出血および／または静脈閉塞症を治療および／または予防するための方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020508563A Pending JP2020531452A (ja) | 2017-08-15 | 2018-08-14 | 造血幹細胞移植に関連する移植片対宿主病および／またはびまん性肺胞出血および／または静脈閉塞症を治療および／または予防するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025072148A Pending JP2025108730A (ja) | 2017-08-15 | 2025-04-24 | 造血幹細胞移植に関連する移植片対宿主病および／またはびまん性肺胞出血および／または静脈閉塞症を治療および／または予防するための方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US11013772B2 (https=) |
| EP (1) | EP3668531A4 (https=) |
| JP (3) | JP2020531452A (https=) |
| KR (3) | KR20250150131A (https=) |
| CN (3) | CN118436776A (https=) |
| AU (1) | AU2018318982B2 (https=) |
| BR (1) | BR112020003207A2 (https=) |
| CA (1) | CA3072940A1 (https=) |
| CL (3) | CL2020000384A1 (https=) |
| GE (2) | GEP20237541B (https=) |
| IL (3) | IL272674B2 (https=) |
| JO (1) | JOP20200021A1 (https=) |
| MA (1) | MA49915A (https=) |
| MX (3) | MX2020001728A (https=) |
| MY (1) | MY210026A (https=) |
| PH (1) | PH12020500276A1 (https=) |
| SG (1) | SG11202001014WA (https=) |
| TW (3) | TWI818919B (https=) |
| WO (1) | WO2019036460A1 (https=) |
| ZA (1) | ZA202407503B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11584714B2 (en) | 2018-05-29 | 2023-02-21 | Omeros Corporation | MASP-2 inhibitors and methods of use |
| CN112867706B (zh) | 2018-05-29 | 2024-11-15 | 奥默罗斯公司 | Masp-2抑制剂和使用方法 |
| WO2021108447A1 (en) * | 2019-11-26 | 2021-06-03 | Omeros Corporation | Methods for treating and/or preventing idiopathic pneumonia syndrome (ips) and/or capillary leak syndrome (cls) and/or engraftment syndrome (es) and/or fluid overload (fo) associated with hematopoietic stem cell transplant |
| JP7699389B2 (ja) | 2019-12-04 | 2025-06-27 | オメロス コーポレーション | Ｍａｓｐ－２阻害剤および使用方法 |
| IL293550A (en) | 2019-12-04 | 2022-08-01 | Omeros Corp | 2-masp inhibitor compounds, preparations containing them and their uses |
| BR112022010881A2 (pt) | 2019-12-04 | 2022-08-23 | Omeros Corp | Composto, composição farmacêutica, e, método para tratar uma doença ou distúrbio associado a serina protease-2 associada à lectina de ligação ao manan |
| EP4069676A1 (en) | 2019-12-04 | 2022-10-12 | Omeros Corporation | Masp-2 inhibitors and methods of use |
| AU2021313124A1 (en) * | 2020-07-22 | 2023-03-09 | Beijing Tide Pharmaceutical Co., Ltd. | Method for treating graft versus host disease caused by hematopoietic stem cell transplantation |
| CN113057142B (zh) * | 2021-03-30 | 2022-12-09 | 四川大学华西医院 | 一种视网膜内和/或视网膜下纤维化动物模型的构建方法 |
| TW202305010A (zh) * | 2021-04-25 | 2023-02-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 抗ｍａｓｐ２抗體、其抗原結合片段及醫藥用途 |
| WO2023108028A2 (en) | 2021-12-10 | 2023-06-15 | Omeros Corporation | Therapeutic antibodies that bind to the serine protease domain of masp-2 and uses thereof |
| CN114532982A (zh) * | 2022-01-12 | 2022-05-27 | 高谋 | 评价干细胞系统移植调控补体活化作用的体系 |
| CN114686585B (zh) * | 2022-04-01 | 2023-06-30 | 中国人民解放军总医院 | Tmem65在预警和/或治疗高原病中的应用 |
| JP2025541737A (ja) | 2022-11-30 | 2025-12-23 | オメロス コーポレーション | Ｍａｓｐ－２阻害物質としての縮合ピリミジン |
| US20250122225A1 (en) | 2023-10-06 | 2025-04-17 | Omeros Corporation | Masp-2 inhibitors and methods of use |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4331647A (en) | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
| US4394370A (en) | 1981-09-21 | 1983-07-19 | Jefferies Steven R | Bone graft material for osseous defects and method of making same |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4526909A (en) | 1984-01-09 | 1985-07-02 | Regents Of The University Of California | Polymethylmethacrylate delivery system for bone morphogenetic protein |
| US4563489A (en) | 1984-02-10 | 1986-01-07 | University Of California | Biodegradable organic polymer delivery system for bone morphogenetic protein |
| JPH0662679B2 (ja) | 1985-06-21 | 1994-08-17 | 新田ゼラチン株式会社 | 組織親和性コラ−ゲンとその製法 |
| US5453566A (en) | 1986-03-28 | 1995-09-26 | Calgene, Inc. | Antisense regulation of gene expression in plant/cells |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| ATE115999T1 (de) | 1987-12-15 | 1995-01-15 | Gene Shears Pty Ltd | Ribozyme. |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| GB8822492D0 (en) | 1988-09-24 | 1988-10-26 | Considine J | Apparatus for removing tumours from hollow organs of body |
| US5211657A (en) | 1988-11-07 | 1993-05-18 | The United States Government As Represented By The Secretary Of The Department Of Health And Human Services | Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5549910A (en) | 1989-03-31 | 1996-08-27 | The Regents Of The University Of California | Preparation of liposome and lipid complex compositions |
| SG46445A1 (en) | 1990-01-26 | 1998-02-20 | Immunomedics Inc | Vaccines against cancer and infectious diseases |
| JP3218637B2 (ja) | 1990-07-26 | 2001-10-15 | 大正製薬株式会社 | 安定なリポソーム水懸濁液 |
| US5789573A (en) | 1990-08-14 | 1998-08-04 | Isis Pharmaceuticals, Inc. | Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2 |
| JP2958076B2 (ja) | 1990-08-27 | 1999-10-06 | 株式会社ビタミン研究所 | 遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法 |
| IL108367A0 (en) | 1993-01-27 | 1994-04-12 | Hektoen Inst For Medical Resea | Antisense polynzcleotide inhibition of human growth factor-sensitive cancer cells |
| US5801154A (en) | 1993-10-18 | 1998-09-01 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of multidrug resistance-associated protein |
| US5856121A (en) | 1994-02-24 | 1999-01-05 | Case Western Reserve University | Growth arrest homebox gene |
| US5741516A (en) | 1994-06-20 | 1998-04-21 | Inex Pharmaceuticals Corporation | Sphingosomes for enhanced drug delivery |
| AU4467396A (en) | 1994-12-12 | 1996-07-10 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain, inflammation and spasm |
| US5795587A (en) | 1995-01-23 | 1998-08-18 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
| US5738868A (en) | 1995-07-18 | 1998-04-14 | Lipogenics Ltd. | Liposome compositions and kits therefor |
| US5739119A (en) | 1996-11-15 | 1998-04-14 | Galli; Rachel L. | Antisense oligonucleotides specific for the muscarinic type 2 acetylcholine receptor MRNA |
| RU2271825C2 (ru) | 1999-07-21 | 2006-03-20 | Омерос Корпорейшн | Растворы и способы ингибирования боли, воспаления и разрушения хряща |
| US6649592B1 (en) | 2000-01-14 | 2003-11-18 | Science & Technology Corporation @ Unm | Peptide inhibitors of LFA-1/ICAM-1 interaction |
| SG98393A1 (en) | 2000-05-19 | 2003-09-19 | Inst Materials Research & Eng | Injectable drug delivery systems with cyclodextrin-polymer based hydrogels |
| EP1496835A4 (en) | 2002-02-01 | 2006-10-18 | Omeros Corp | COMPOSITIONS AND METHODS FOR THE SYSTEMIC SUPPRESSION OF CARTON DECOMPOSITION |
| AU2003249317B2 (en) | 2002-07-19 | 2007-08-02 | Institute Of Materials Research And Engineering | Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from |
| EP1625166B1 (en) | 2003-05-12 | 2015-04-08 | Helion Biotech ApS | Antibodies to masp-2 |
| CN101065148A (zh) * | 2003-07-03 | 2007-10-31 | 奥索-麦克尼尔药品公司 | 结合补体级联抑制剂 |
| US7919094B2 (en) | 2004-06-10 | 2011-04-05 | Omeros Corporation | Methods for treating conditions associated with MASP-2 dependent complement activation |
| JP2008540385A (ja) * | 2005-05-06 | 2008-11-20 | ラボラトワール セローノ ソシエテ アノニム | 疾患を治療するための免疫グロブリンドメイン含有細胞表面認識分子の使用 |
| EP2606058B1 (en) * | 2010-07-21 | 2017-03-08 | Eastern Virginia Medical School | Peptide compounds to regulate the complement system |
| US9644035B2 (en) * | 2011-04-08 | 2017-05-09 | Omeros Corporation | Methods for treating conditions associated with MASP-2 dependent complement activation |
| US20150166676A1 (en) * | 2011-04-08 | 2015-06-18 | Omeros Corporation | Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation |
| EP2704743B1 (en) * | 2011-05-04 | 2020-03-11 | Omeros Corporation | Compositions for inhibiting masp-2 dependent complement acitivation |
| AU2014209350B8 (en) | 2013-01-23 | 2019-04-18 | Department Of Veterans Affairs (Us) | Targeting constructs based on natural antibodies and uses thereof |
| SMT202000659T1 (it) * | 2013-10-17 | 2021-01-05 | Omeros Corp | Metodi per il trattamento delle condizioni associate all'attivazione del complemento dipendente dalla masp-2 |
| CN106687123A (zh) * | 2014-06-05 | 2017-05-17 | 科罗拉多州大学评议会 | Map44多肽和基于天然抗体的构建体及其用途 |
| CA2988313A1 (en) * | 2015-06-08 | 2016-12-15 | Volution Immuno Pharmaceuticals Sa | Ornithodoros moubata complement inhibitor for use in the treatment of acute graft versus host disease |
| CN108472347B (zh) * | 2015-11-09 | 2023-09-05 | 奥默罗斯公司 | 用于治疗与masp-2依赖性补体活化相关的病况的方法 |
-
2018
- 2018-08-13 TW TW107128182A patent/TWI818919B/zh active
- 2018-08-13 TW TW112136719A patent/TWI881481B/zh active
- 2018-08-13 TW TW114113955A patent/TW202529812A/zh unknown
- 2018-08-14 MX MX2020001728A patent/MX2020001728A/es unknown
- 2018-08-14 MY MYPI2024000764A patent/MY210026A/en unknown
- 2018-08-14 EP EP18845831.9A patent/EP3668531A4/en active Pending
- 2018-08-14 MA MA049915A patent/MA49915A/fr unknown
- 2018-08-14 GE GEAP201815297A patent/GEP20237541B/en unknown
- 2018-08-14 SG SG11202001014WA patent/SG11202001014WA/en unknown
- 2018-08-14 KR KR1020257031404A patent/KR20250150131A/ko active Pending
- 2018-08-14 GE GEAP202315297A patent/GEAP202315297A/en unknown
- 2018-08-14 CN CN202410427006.0A patent/CN118436776A/zh active Pending
- 2018-08-14 KR KR1020247021113A patent/KR102863808B1/ko active Active
- 2018-08-14 IL IL272674A patent/IL272674B2/en unknown
- 2018-08-14 US US16/103,332 patent/US11013772B2/en active Active
- 2018-08-14 IL IL315724A patent/IL315724A/en unknown
- 2018-08-14 KR KR1020207006893A patent/KR102679441B1/ko active Active
- 2018-08-14 IL IL315726A patent/IL315726A/en unknown
- 2018-08-14 BR BR112020003207-7A patent/BR112020003207A2/pt unknown
- 2018-08-14 WO PCT/US2018/046690 patent/WO2019036460A1/en not_active Ceased
- 2018-08-14 CA CA3072940A patent/CA3072940A1/en active Pending
- 2018-08-14 AU AU2018318982A patent/AU2018318982B2/en active Active
- 2018-08-14 JP JP2020508563A patent/JP2020531452A/ja active Pending
- 2018-08-14 JO JOP/2020/0021A patent/JOP20200021A1/ar unknown
- 2018-08-14 CN CN202410427005.6A patent/CN118634322A/zh active Pending
- 2018-08-14 CN CN201880052958.1A patent/CN111278449B/zh active Active
-
2020
- 2020-02-06 PH PH12020500276A patent/PH12020500276A1/en unknown
- 2020-02-12 MX MX2024012815A patent/MX2024012815A/es unknown
- 2020-02-12 MX MX2024012816A patent/MX2024012816A/es unknown
- 2020-02-14 CL CL2020000384A patent/CL2020000384A1/es unknown
-
2021
- 2021-04-09 US US17/226,987 patent/US11896621B2/en active Active
-
2022
- 2022-01-25 CL CL2022000195A patent/CL2022000195A1/es unknown
- 2022-01-25 CL CL2022000194A patent/CL2022000194A1/es unknown
-
2023
- 2023-06-21 JP JP2023101662A patent/JP2023123627A/ja active Pending
- 2023-12-06 US US18/531,118 patent/US20240293465A1/en active Pending
-
2024
- 2024-10-02 ZA ZA2024/07503A patent/ZA202407503B/en unknown
-
2025
- 2025-04-24 JP JP2025072148A patent/JP2025108730A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023123627A5 (https=) | ||
| JP2021514973A5 (https=) | ||
| JP2011506483A5 (https=) | ||
| CN103298833B (zh) | β淀粉样蛋白结合蛋白 | |
| TWI531377B (zh) | 骨關節炎及疼痛之治療 | |
| RU2008149918A (ru) | Антитела к nkg2a и их применения | |
| TW202115114A (zh) | 針對靶向ｂ細胞成熟抗原的多特異抗體之給藥方案及組合療法 | |
| JP2018527903A5 (https=) | ||
| IL272674B2 (en) | Preparations for use in the treatment or prevention of graft-versus-graft disease or disseminated intravascular hemorrhage or veno-occlusive disease associated with hematopoietic stem cell transplantation | |
| TW201124427A (en) | IL-1 binding proteins | |
| JP2014503202A (ja) | ＴＮＦ−α結合性タンパク質 | |
| RU2008140947A (ru) | Антитела к egfl7 и способы их применения | |
| JPWO2019165421A5 (https=) | ||
| JPWO2022053654A5 (https=) | ||
| PE20250390A1 (es) | Anticuerpos anti-c3 y fragmentos de union al antigeno de estos y sus usos para tratar enfermedades oftalmicas u oculares | |
| JPWO2022053655A5 (https=) | ||
| JPWO2022076462A5 (https=) | ||
| JPWO2022053656A5 (https=) | ||
| JPWO2020210512A5 (https=) | ||
| JPWO2022053653A5 (https=) | ||
| JPWO2022053657A5 (https=) | ||
| JPWO2022053658A5 (https=) | ||
| JPWO2021108447A5 (https=) | ||
| JPWO2023009498A5 (https=) | ||
| JPWO2023049694A5 (https=) |